You are not logged in [login] | [register]

you are here: home » science » science & education:

SEARCH FOR A FEED

Google
Web RSSMad.com

Searching 180633 articles in 8938 feeds.

RSS CATEGORIES

TELL A FRIEND

Do you like RSS MAD? Why not spread the news and tell a friend about it - it's as easy as filling out this form!

PR Web: Technology Biotechnology

added: Wed, 28th September 2005 | 411 views | 0x in favourites
feed url: http://www.prweb.com/xml/biotechnology.xml

PR Web (The Free Wire Service) Technology Biotechnology News

Latest feed entries:

First Heart Failure Patients Successfully Implanted with Angioblast Systems' "Off-the-Shelf" Adult Stem Cells : Multiple US medical centers activly enrolling patients into first Phase 2 trial of allogeneic stem cells for congestive heart failure

Angioblast Systems Inc. today announced successful initial safety results following commencement of the world’s first clinical trial to use allogeneic adult stem cells obtained from an unrelated, universal donor to treat patients with congestive heart failure. (PRWeb Oct 12, 2008)

Read the full story at http://www.prweb.com/releases/heart_failure/stem_cells/prweb1462214.htm

DIA 7th Annual Electronic Submissions Conference: eCTD

The Drug Information Association's (DIA's) 7th Annual Electronic Submissions Conference ECTD: The Adventure Continues (November 5-7; San Diego, CA) will focus on the practical experience gained, lessons learned, and resulting best practices as the pharma industry moves to a fully electronic drug application submission paradigm. (PRWeb Oct 10, 2008)

Read the full story at http://www.prweb.com/releases/DIA/ECTD/prweb1452034.htm

Ascent Scientific Launches First Commercial Source of VU0155041 - to Help Research into Parkinson's Disease

Ascent Scientific (www.ascentscientific.com) announced the availability of the first commercial source of VU0155041 - a new research tool that will aid research into Parkinson's Disease. VU0155041 is the latest addition to the Low-Cost Ligand range. It acts as a selective positive allosteric modulator at the mGlu4 glutamate receptor subtype. These receptors are thought to be involved in many neurological conditions including Parkinson's Disease. (PRWeb Oct 9, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1438374.htm

Women and Children's Health Research Institute Adds to OpenClinica Software Developer Community

The Women and Children's Health Research Institute, a collaboration between the University of Alberta and Alberta Health Services, announces it has joined the OpenClinica open source developer community. The Institute has become an active contributor to the popular open source http://www.openclinica.org [clinical trials software] project. (PRWeb Oct 9, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1440334.htm

EnrichMap Announces New Program To Reduce Medical Patient Noncompliance And Offers Healthcare Organizations A Limited Trial Test Opportunity

Medical patient noncompliance is a major healthcare issue. The Emap typology provides a new patient assessment program to determine the compliance personality of individuals and then targeted guidance for how to best communicate healthcare information to each of the six compliance Profiles (PRWeb Oct 8, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1434244.htm

DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress

Drug Information Association (DIA) will host the 6th Canadian Annual Meeting (November 5-7; Ottawa, Ontario, Canada) to discuss a number of important issues facing Health Canada, the pharmaceutical industry, health academia, and the health care system. (PRWeb Oct 8, 2008)

Read the full story at http://www.prweb.com/releases/DIA/Canadian-Annual-Meeting/prweb1439644.htm

"Put Down the BBQ Ribs, We've Found You a Donor Heart," Nurse Tells Patient : Ohio Father near Death Gets Second Chance at Life with CardioWest™ temporary Total Artificial Heart

After a six-year battle with heart disease that included numerous medications, trips to the emergency room and surgery to implant a pacemaker, 40-year-old Jim Fijalkovich found himself in the Intensive Care Unit at an Ohio hospital. Both sides of his heart were dying and he was in desperate need of a transplant. (PRWeb Oct 8, 2008)

Read the full story at http://www.prweb.com/releases/artificial_heart/total_artificial/prweb1444944.htm

POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol

POET today announced that it will receive $76.3 million from the U.S. Department of Energy (DOE) to commercialize cellulosic ethanol production technology. (PRWeb Oct 7, 2008)

Read the full story at http://www.prweb.com/releases/POET/Ethanol/prweb1439954.htm

Glemser Announces New Labeling Solution: SPL for DCM Addresses New SPL Release 4 Requirements

Glemser Technologies, a Bethlehem, PA based pharmaceutical software and services company, today announced SPL for DCM, a new out-of-the-box labeling solution based on Documentum's Documentum Compliance Manager (DCM) application. SPL for DCM provides a complete labeling content management solution and addresses the SPL Release 4 submission standard mandated by the FDA, and represents the latest addition to Glemser's family of pharmaceutical labeling solutions. (PRWeb Oct 6, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1417584.htm

Octapharma USA Retains Yankee Public Relations as its Agency of Record

Octapharma USA, a subsidiary of the largest privately owned plasma products company in the world, has selected Yankee Public Relations of Alexandria Township, N.J. as its public relations firm of record. (PRWeb Oct 6, 2008)

Read the full story at http://www.prweb.com/releases/octapharma/pharmaceutical/prweb1423854.htm

Olympus Announces U.S. Release of Progesterone Assay for Olympus AU3000i® Immunoassay System

Olympus, a leader in the field of in vitro diagnostics, has introduced a progesterone immunoassay for sale in the U.S. (PRWeb Oct 6, 2008)

Read the full story at http://www.prweb.com/releases/progesterone_assay/olympus/prweb1432094.htm

Applied Biosystems, Amaxa, and Invitrogen Lead Attractive Gene Silencing Market - Revealed in New Life Science Dashboard™ Market Research Report : Interest in Switching Suppliers Up Significantly Compared to 2007 Life Science Dashboard™ from Percepta Associates

Today Percepta Associates released Series Two of its Gene Silencing Life Science Dashboard™ market research report. This market research report, which analyzes key market indicators, such as market size and market growth rate, for specific gene silencing segments, reveals that Applied Biosystems (NYSE:ABI), Amaxa (SWX:Lonn) and Invitrogen (NASDAQ:IVGN), are leading suppliers of research products and kits for gene silencing and gene knockdown researchers. ThermoFisher Scientific (NYSE:TMO), Sigma-Aldrich (NASDAQ:SIAL), Roche Applied Sciences, a division of Roche Diagnostics (VTX:ROG.VX), Bio-Rad Laboratories (AMEX:BIO) and Qiagen (NASDAQ:QGEN) share leadership in specific gene silencing application segments in this 2008 report. Gene silencing is a powerful method of artificially inducing a shutdown of specific targeted genes expressed in cells. Gene silencing methods are increasingly used in gene function studies, drug target validation, and the development of therapeutics. (PRWeb Oct 6, 2008)

Read the full story at http://www.prweb.com/releases/gene_silencing/life_science/prweb1432974.htm

National Push Needed for Better Utilization of Seafood Byproducts

Strategro offers vision for better utilization of seafood byproduct materials and details critical weaknesses of current situation, at Pacific Rim Summit on Industrial Biotechnology and Bioenergy, held recently in Vancouver, BC. (PRWeb Oct 6, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1419864.htm

New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS

Partnering with the University of Aberdeen and Rothamsted Research for releasing natural insect repellents that protect against the Scottish biting midge, Atrium Innovation's new electrostatic spray technology is set to revolutionise how people protect buildings from unwanted particles, insects, germs and bacteria. (PRWeb Oct 3, 2008)

Read the full story at http://www.prweb.com/releases/Atrium_Innovation/Spray_Technology/prweb1411884.htm

NextBio Crosses Threshold to Fastest Growing Life Science Search Engine on the Web : NextBio Used by Over 300,000 Researchers Since Public Launch

NextBio, a life science search engine that empowers researchers and clinicians to search and correlate public scientific data and literature, share their own research findings and collaborate with colleagues, today announced that over 150,000 unique monthly visitors used its website in September 2008. Since the launch of its publicly available search engine earlier this year, NextBio has served over 300,000 researchers and clinicians spanning over 200 countries. In addition to the free public version of the NextBio search engine, NextBio offers a powerful enterprise solution with a suite of exclusive features for pharmaceutical and biotechnology companies and major academic and governmental research institutions. (PRWeb Oct 2, 2008)

Read the full story at http://www.prweb.com/releases/search_engine/science_search/prweb1417594.htm

The Billion Dollar Transition From Fitness To Health

The report, "Wireless Healthcare 2008", examines a number of companies that have successfully deployed wireless based healthcare services using various business models and technology platforms. (PRWeb Oct 2, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1407174.htm

Process Safety and Thermal Hazard Analysis Fall Webinar Series presented by METTLER TOLEDO

METTLER TOLEDO is pleased to announce that Dr. Francis Stoessel, a leading Process Safety Consultant with the Swiss Safety Institute (SWISSI), will be the Keynote Speaker in the Process Safety and Thermal Hazard Analysis Webinar Series. (PRWeb Oct 1, 2008)

Read the full story at http://www.prweb.com/releases/Process/Safety/prweb1402164.htm

Monitor Granule Growth in Process with the FBRM® C35

METTLER TOLEDO announces the launch of the FBRM® C35, designed to target granule size in real time. (PRWeb Oct 1, 2008)

Read the full story at http://www.prweb.com/releases/granulation/development/prweb1402434.htm

Akaza Research, LLC Becomes Licensed caBIG® Support Service Provider

The National Cancer Institute has accepted Akaza Research, LLC as a licensed caBIG® Support Service Provide. (PRWeb Oct 1, 2008)

Read the full story at http://www.prweb.com/releases/2008/10/prweb1401184.htm

New England Peptide Names Director of Chemical Development

New England Peptide, LLC (NEP), has named Robert P. Hammer, Ph.D., director of chemical development. (PRWeb Sep 30, 2008)

Read the full story at http://www.prweb.com/releases/peptides/research/prweb1388964.htm

DIA Co-located Conference to Examine Outsourcing and Project Management Best Practices

The Drug Information Association (DIA) will host two co-located conferences from October 23-24 in Washington DC. (PRWeb Sep 30, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1401994.htm

The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System

The HeartAssist 5™ Pediatric VAD will be introduced for the first time in the U.S. at the 16th annual meeting of the International Society for Rotary Blood Pumps (ISRBP) in Houston on Oct. 2-4. (PRWeb Sep 30, 2008)

Read the full story at http://www.prweb.com/releases/pediatric_vad/blood_flow/prweb1406304.htm

Baxa Corporation Announces USP 797 Course to be Hosted at the STAR Center

Baxa announces it has signed a hosting agreement with the United States Pharmacopeia (USP) for compliance training through the Baxa STAR Center (Skills Training, Academics and Resources) continuing education facility in Englewood, Colorado. Baxa and USP plan to hold 16 sessions of their Compliance Tools for USP 797 course in 2009. (PRWeb Sep 30, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1387964.htm

Third NLN Technology Conference Features Keynoter Angela McBride October 31 -November 2 Goldfarb School of Nursing at Barnes-Jewish College St. Louis, MO

Intended to help nurse educators remain current in rapidly evolving areas, the NLN Technology Conference brings together recognized experts in simulation, e-learning, informatics, and telehealth including Diane Billings, Helen Connors, Pamela Jeffries, and Diane Skiba. (PRWeb Sep 28, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1392724.htm

DIA 2nd Annual Clinical Forum: Data Driven Drug Development Decisions

Following a very successful first event in 2007, the Drug Information Association's (DIA's) 2nd Annual Clinical Forum: Data Driven Drug Development Decisions (October 20-23, 2008; Ljubljana, Slovenia) will focus on clinical data. (PRWeb Sep 26, 2008)

Read the full story at http://www.prweb.com/releases/Clinical_Research/Drug_Development/prweb1387234.htm

Presidio Pay Advisors Releases Salary GPS Tool

Compensation consulting firm plans to release several proprietary diagnostic models that are designed to identify potential compensation issues within a company. (PRWeb Sep 25, 2008)

Read the full story at http://www.prweb.com/releases/2008PresidioPay/SalaryGPS/prweb1383384.htm

RNL Bio Offers Special Dog Cloning Opportunity at $50,000

RNL Bio offers an exceptional promotion for dog cloning at hugely discounted price. (PRWeb Sep 25, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1378714.htm

Animetrics® Inc. Named One of Business NH Magazine's '10 Companies to Watch' for its Significant Revenue Growth

Business Journal to Honor Animetrics at "Top 100 Private Companies" Event in October (PRWeb Sep 24, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1378184.htm

DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation

Recent reports have brought attention to the Food and Drug Administration's (FDA's) plan to list those drugs whose safety is under investigation because of complaints brought to the agency's attention by drug companies, physicians, and patients. (PRWeb Sep 24, 2008)

Read the full story at http://www.prweb.com/releases/Drug_Safety/Conference/prweb1375654.htm

Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria

Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the Company and its partner, Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp), will initially focus their collaboration on developing point-of-care (P-O-C) diagnostics and drug delivery systems for tropical diseases, such as malaria. BiotechCorp has acquired an exclusive, global license to a Nanobiotix nanotechnology platform for non-cancer purposes. As part of the collaboration, three BiotechCorp scientists will take up residence at Nanobiotix for a period of 12 months to undergo the technology transfer training. (PRWeb Sep 24, 2008)

Read the full story at http://www.prweb.com/releases/drug_delivery/delivery_systems/prweb1380404.htm

New and Updated Online Tutorials for ASTD, Entrez Protein and MMDB

Comprehensive tutorials on the ASTD, Entrez Protein, and MMDB databases enable researchers to quickly and effectively use these invaluable variation resources. (PRWeb Sep 24, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1369684.htm

Synamatix Partners With GeneWorks to Deliver Next-generation Sequencing and Bioinformatics Support for Key Research Institutions in Asia and Australia

Synamatix today announced its partnership with GeneWorks for the provision of sequencing and bioinformatics research support to key customers within Asia and Australia. The two companies will provide genome institutes in Asia with an extensive and comprehensive range of sequencing and bioinformatics solutions to support and enhance research. (PRWeb Sep 24, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1367114.htm

McCain and Obama on Bio-threat Detection and Pandemic Response: QualSec Weighs in

NanoNose Offers the Technology Both Candidates Think is Crucial (PRWeb Sep 23, 2008)

Read the full story at http://www.prweb.com/releases/election/bioterrorism/prweb1370734.htm

Nano-Bio-Info-Cogno Revolutions to be Explored at Convergence08 Unconference - Forecaster Paul Saffo to Keynote

The Convergence08 conference (www.convergence08.org) on Nano-Bio-Info-Cogno (NBIC) technologies and their interactions will be held November 15-16 at the Computer History Museum in Mountain View, California. The event will use an innovative "unconference" format to enable participants to customize the event in a highly interactive way. Paul Saffo, a Silicon Valley forecaster with over two decades experience exploring long-term technological change and its practical impact on business and society, will keynote the event. (PRWeb Sep 23, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1366394.htm

Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit

Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today launched BioNuesisTM, the only soluble human extracellular matrix (ECM) developed as a culturing kit for stem cell growth. The kit was launched and is being exhibited at the 2008 World Stem Cell Summit taking place in Madison, Wisconsin. (PRWeb Sep 22, 2008)

Read the full story at http://www.prweb.com/releases/BioNuesis/Histogen/prweb1355104.htm

Colorado BioScience Association, Colorado Springs Economic Development Corporation and CEA Technologies, Inc., Promote the State's Bioscience Industry at the 2008 AdvaMed MedTech Conference in Washington D.C.

The Colorado BioScience Association (CBSA), Colorado Springs Economic Development Corporation and CEA Technologies, Inc. are joining forces to promote the State's burgeoning bioscience industry at the AdvaMed 2008 MedTech Conference in Washington, D.C., September 21-24. Participation in this premier event for medical device manufacturers will showcase Colorado's CEA Technologies, Inc., a leader in the contract design and manufacture of disposable and reusable electromechanical devices used in critical care applications for Fortune 20 medical device companies. (PRWeb Sep 22, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1362894.htm

BIT Group to Host Conference in Quality Management/Process Optimization

Global contract manufacturer of complex medical instrumentation will host an on-site conference targeting Medical Device OEM's and Suppliers interested in improving quality management and enhancing process optimization. (PRWeb Sep 22, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1359374.htm

Progenitor Cell Therapy Strengthens Personnel Roster

Contract manufacturer PCT announces key hiring and promotions (PRWeb Sep 21, 2008)

Read the full story at http://www.prweb.com/releases/2008/09/prweb1361104.htm

ADD A FEED

Is RSS MAD missing something? Tell us about new feeds here.